ArticleGynecologic and obstetric investigation2026
Maternal Use of Fertility Treatments and the Risk for Celiac Disease in the Offspring.
Article in Gynecologic and obstetric investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFertility treatments affect the maternal hormonal and immunological milieu, which also support the developing fetus. Given that celiac disease is an immune-mediated disorder, it has been hypothesized that fertility treatments may influence immune programming in utero and potentially increase the risk of immune-related conditions in the offspring, such as celiac disease.
objectiveWe sought to investigate whether offspring conceived following fertility treatments are at increased risk of developing celiac disease during childhood. STUDY
designA large population-based cohort study was conducted, including all singleton deliveries at a tertiary medical center between the years 1991 and 2021. The risk of developing celiac disease was compared between offspring (followed up to the age of 18) of women who conceived using fertility treatments - including ovulation induction and in vitro fertilization - and those born following natural conception. Data regarding celiac disease diagnoses were extracted from community-based clinics and hospitalization records of the offspring. Kaplan-Meier survival analysis was used to compare the cumulative incidence of celiac disease between the study groups. A Cox proportional hazards model was applied to control for potential confounders.
resultsA total of 356,356 singleton deliveries were included in the study, of which 7,711 (2.2%) were conceived using fertility treatments. Offspring born following fertility treatments had a comparable rate of celiac disease to those born after natural conception (0.6% vs. 0.5%, p = 0.477). Kaplan-Meier survival analysis demonstrated similar cumulative incidence of celiac disease between the groups (log-rank test, p = 0.285). In a Cox proportional hazards model, adjusted for maternal age and gestational age, fertility treatments were not associated with an increased risk of celiac disease in the offspring (adjusted hazard ratio = 1.13, 95% confidence interval 0.84-1.52, p = 0.392). LIMITATIONS: Follow-up was limited to age 18, and cases diagnosed later in life could not be captured.
conclusionIn our large cohort with long-term follow up, fertility treatments were not associated with an increased risk of celiac disease in the offspring up to the age of 18.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.